The largest database of trusted experimental protocols

Oasis hlb c18 cartridges

Manufactured by Waters Corporation
Sourced in United States

The Oasis HLB C18 cartridges are a type of solid-phase extraction (SPE) product manufactured by Waters Corporation. They are designed for the purification and concentration of analytes from liquid samples. The Oasis HLB C18 cartridges utilize a reversed-phase sorbent material to selectively retain and elute target compounds.

Automatically generated - may contain errors

6 protocols using oasis hlb c18 cartridges

1

Isobaric Peptide Fractionation and Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteomics procedures are scheduled in Supplementary Fig. S3 and fully described in Supplementary Information. The peptide pools were isobarically labelled (iTRAQ, Sigma-Aldrich), equally mixed and the peptide mixture was desalted onto Oasis HLB C18 cartridges (Waters). One-fifth of the tagged peptides were dried-down, and the remaining four-fifths were separated into 8 fractions using MCX Oasis cartridges (Waters). The peptide fractions were desalted using MicroSpin Colums C18 (The Next Group) and vacuum-dried.
+ Open protocol
+ Expand
2

Automated N-Glycopeptide Enrichment

Check if the same lab product or an alternative is used in the 5 most similar protocols
5 µL of individual human serum from GC patients, healthy controls, or QC samples were diluted ten times with 8 M urea/0.1 M NH4HCO3, and then denatured by reduction (with 20 mM DTT at 37 °C for 2 h) followed by alkylation (with 40 mM IAA at 25 °C for 40 min). After urea concentration of the mixture was reduced to below 2 M with 0.1 M NH4HCO3, protein digestion was carried out with trypsin at an enzyme‐to‐protein ratio of 1:50 (w/w) at 37 °C for 16 h. Tryptic peptides were subsequently desalted using Oasis HLB C18 cartridges (Waters) and then lyophilized. Glycopeptide enrichment and MS analysis of intra‐batch samples were performed randomly to avoid bias. Intact N‐glycopeptides were enriched by the automated N‐glycopeptide enrichment method, according to previously reported.[23 (link)
] In brief, the lyophilized tryptic peptides were redissolved in 0.1% TFA/80% ACN and injected automatically onto a HILIC column at a flow rate of 200 µL min−1. The glycopeptide fraction was collected after the non‐glycopeptide fraction was previously washed away. The following sample could be injected after system washing and re‐equilibration. The whole enrichment cycle for each sample needs 20 min.
+ Open protocol
+ Expand
3

Quantitative Proteomics Using FASP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each sample was digested using the filter-aided sample preparation method (FASP) (Wiśniewski et al., 2009 (link)). Protein samples were denatured with 20 mM DTT at 37 °C for 1 h and alkylated with 50 mM IAA in darkness for 45 min. Then, the samples were loaded onto filter devices with a cut-off of 10 kD (Pall, Port Washington, NY, USA) and centrifuged at 14,000g at 18 °C. After washing twice with UA (8 M urea in 0.1 M Tris-HCl, pH 8.5) and twice with 25 mM NH4HCO3, the samples were redissolved in 25 mM NH4HCO3 and digested with trypsin (enzyme to protein ratio of 1:50) at 37 °C overnight. The digested peptides were collected as a filtrate and desalted using Oasis HLB C18 cartridges (Waters, Milford, MA). The IgAN 1-3 and pMN samples were individually labelled with 114, 115, 116, and 117 4-plex iTRAQ chemistry according to the manufacturer’s protocol (ABsciex, Framingham, MA, USA).
+ Open protocol
+ Expand
4

iTRAQ Labeling and Peptide Fractionation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For iTRAQ (isobaric Tags for Relative and Absolute Quantification) labeling, the dried peptides were taken up in 30 μL of 0.5 M triethylammoniumbicarbonate (TEAB) buffer and labeled with the corresponding iTRAQ reagent in 70% (v/v) ethanol for 1 h at room temperature. Then, 100 μL of 0.5% (v/v) trifluoroacetic acid (TFA) was added to stop the labeling reaction. The peptide samples were mixed, vacuum concentrated and diluted in 200 μL of 1% (v/v) TFA for desalting on Oasis HLB C18 cartridges (Waters). One-fourth of the tagged peptides were directly analyzed by LC-MS, and the remaining three-fourths were subject to mixed-mode cationic exchange (MCX) fractionation. The iTRAQ-labeled peptides were suspended in 5 mM ammonium formate with 25% (v/v) acetonitrile (ACN), pH 3.0, and separated into 5 fractions using MCX Oasis cartridges (Waters). The so-obtained peptide fractions were desalted using MicroSpin Columns C18 (The Next Group), vacuum-dried and kept at 4 °C for later LC-MS analysis.
+ Open protocol
+ Expand
5

iTRAQ Peptide Prefractionation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
iTRAQ-labeled samples were desalted using Oasis HLB C18 cartridges (Waters, Milford, MA, USA) and dried using a vacuum centrifuge. Peptides were then prefractionated using MCX Oasis columns (Waters) and increasing concentrations (50, 100, 200, 300, 400, 500, 600, 700, 800, and 900 mM and 1, 1.5, and 2 M) of ammonium formate. A total of 13 fractions were collected and individually washed using C18 cartridges, after which they were dried.
+ Open protocol
+ Expand
6

Liver Proteome Extraction and Digestion

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver tissues were homogenized in an ice-cold phosphate buffer saline (PBS) solution containing 8 M urea with 100 passes of a Wheaton homogenizer. Homogenate solution was collected, sonicated, and centrifuged at 13,000 rpm for 10 min (4°C). Supernatants were collected, aliquoted into ~50 μL portions, and stored at -80°C. Protein concentrations were determined using the BCA assay according to the manufacturer's instructions (Pierce Thermo, Rockford, IL, USA). Liver proteins (100 μg and 75 μg) were digested for each sample in cysDML and cPILOT experiments, respectively. After dilution to 1 μg/ μL, the liver proteins were denatured and reduced in 50 mM Tris buffer (pH = 8.2), 8 M urea, 10 mM dithiothreitol (DTT) for 1 h at 37°C. The resulting protein mixture was diluted 10fold with 20 mM Tris buffer (pH = 8.2). TPCK-treated trypsin from bovine pancreas (Sigma, St. Louis, MO, USA) was added to each sample in a 4% w/w enzyme/protein ratio and incubated at 37°C for 18 h. Samples were acidified with 0.5% formic acid, cleaned using Waters Oasis HLB C 18 cartridges, and lyophilized.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!